logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Idera Pharmaceuticals (IDRA) Climbs on Positive Top-line Data from IMO-8400 Phase 2 Trial

By  +Follow March 27, 2014 11:11AM
Share:
Tickers Mentioned:

It’s been a wild week for Idera Pharmaceuticals (IDRA). What started as a modest decline on March 19 after the stock bumped against its rising resistance level at about $6.85 a share turned into a blood bath on Monday when Summer Street Research Partners analysts expressed skepticism about the effectiveness of IMO-8400, the company’s lead therapy. Shares plummeted, and kept falling throughout the week. However, while Thursday brought more losses, it also brought an opinion from Piper Jaffray analysts that ran counter to Summer Street, calling the sell-off premature and overblown.

Now, for the time being at least, it appears as though Piper Jaffray had the right idea. The stock is up over 10 percent in early trading after the release of top-line data from its Phase 2 trial for IMO-8400 that appears to be broadly positive.

Shares gapped up 16.2 percent to $4.51 a share at the opening bell, fell sharply to just under $4.30 immediately afterwards, then quickly began a buying run that pushed the stock as high as $4.75 a share just before 10am ET, a 22.4 percent gain. The stock retreated again, though, falling back below its opening price as the morning wore on.

The phase 2 trial was a double-blind placebo controlled clinical trial involving 32 patients with moderate-to-severe plaque psoriasis. Idera’s IMO-8400 met both the primary objective of evaluating safety and tolerability for the drug, with no treatment related discontinuation and all patients being well tolerated, and its secondary objective of demonstrating clinical activity in patients with psoriasis.

“Successful completion of this trial is an important additional milestone in our TLR antagonist program. We have studied psoriasis as the initial disease indication to demonstrate clinical proof of concept for our TLR antagonists in autoimmune diseases,” said CEO Sudhir Agrawal, D. Phil. “With these data, we can now pursue our announced business strategy and advance our TLR antagonist drug candidates for the treatment of orphan diseases with high unmet medical need. Towards this goal, our clinical development strategy for IMO-8400 is focused on B-cell lymphomas harboring the MYD88 L265P mutation, and on orphan autoimmune disease indications. Over the remainder of 2014, we anticipate enrolling patients in IMO-8400 trials for Waldenström’s macroglobulinemia, diffuse large B-cell lymphoma and polymyositis and dermatomyositis.”

The treatment showed effectiveness and tolerability at three different dosing levels, giving Idera executives reason for optimism.

“We are very pleased to have met the goals of this trial related to safety and tolerability over three months of dosing, and to have obtained evidence of clinical activity with IMO-8400 in psoriasis patients. This provides further validation of the scientific rationale of blocking over-activation of specific TLRs,” said Senior VP and CMO Lou Brenner, 41M.D. “These data also support our clinical development plans for IMO-8400 in genetically defined forms of B-cell lymphoma and orphan autoimmune diseases.”

However, Summer Street analysts appeared to double down on their initial claims about IMO-8400. Analyst Bart Classen observed that did not mention a dosing effect in the recently-released data, something he considered surprising given it was a dosing study and some patients had very low doses.

The day’s gains may also have generated some interesting technical factors for Idera’s stock. While the release of clinical data is clearly what’s fueling the day’s movement, these other factors could be contributing to the strength of the rebound.

The stock has shown a 14-day stochastic RSI below 0.20 since plunging on Monday, a sign that it’s oversold. And as of yesterday’s losses, the 14-day RSI had also dropped below 30, another sign recognized by traders that the stock is oversold. What’s more, Friday’s gains resulted in the signal line crossing the MACD, which is considered a buy sign.

Finally, the fact that the stock bottomed out at just under $3.70 could show the formation of a rising support line at just under $4 a share based on a hard bounce there in late January. This would play against a clearly defined rising resistance line that’s appeared to cap gains since early September of last year. However, given that this supposed support line would be based on only two bounces, one of which corresponds with the release of positive clinical data, it’s hard to place all that much reliance in it.

 

 

Editor's note: this article had previously referred to Summer Street Research Partners as Summer Street Capital Partners, a separate and unafilliated company. It has been edited to correct this mistake.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for IDRA
Stockaholics
23 Nov 14 13:49:32
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $QCOR $FCEL $IDRA
Stockaholics
22 Nov 14 11:26:09
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $QCOR $FCEL $IDRA
Stockaholics
21 Nov 14 18:57:36
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $QCOR $FCEL $IDRA
Stockaholics
21 Nov 14 14:40:04
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $QCOR $FCEL $IDRA
Elias S
21 Nov 14 13:06:20
Paper positions: $CBMX, $SGMS, $ADEP, $IDRA Paper wins: $ABAT
lookn4wins
21 Nov 14 10:52:44
IDRA 2.48 Stock Charts $IDRA Idera Pharmaceuticals Inc. (NASDAQ) Any opinions on IDRA? Please reply to this po http://t.co/TjRKeefNIi
Penny Stock Secret
21 Nov 14 09:18:39
The Most Accurate Penny Stock Alert Service Made $54,000 Yesterday Click here http://t.co/SVqoMlijqL .. $QCOR $FCEL $IDRA
Daily Contracts
21 Nov 14 05:05:01
Real-Time feed of company contracts, original agreements and executive updates from Idera Pharmaceuticals $IDRA http://t.co/eSs9DVYWDc
Stockaholics
21 Nov 14 02:57:38
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $QCOR $FCEL $IDRA
chartguy89
20 Nov 14 23:14:39
IDRA 2.50 Stock Charts $IDRA Idera Pharmaceuticals Inc. (NASDAQ) Last Updated: 11/21/2014 01:14:42 IDRA Stock http://t.co/hoQg6v1X81
Stockaholics
20 Nov 14 13:17:02
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $QCOR $FCEL $IDRA
Daily Contracts
20 Nov 14 13:07:02
Real-Time feed of company contracts, original agreements and executive updates from Idera Pharmaceuticals $IDRA http://t.co/eSs9DVYWDc
clayton
20 Nov 14 12:18:35
IDRA 2.55 Idera Pharmaceuticals $IDRA added to my watch list. Right now with IDRA I am watching the last price http://t.co/81pj4obsrj
clayton
20 Nov 14 12:18:12
$IDRA IDRA 2.55 Idera Pharmaceuticals $IDRA added to my watch list. Right now with IDRA I am watching the last price http://t.co/j6xrs1ZtEc
Penny Stock Secret
20 Nov 14 10:44:06
This �Millionaire Maker� For Traders Shares His Secrets! Click here http://t.co/SVqoMlijqL .. $QCOR $FCEL $IDRA
Elias S
20 Nov 14 10:32:26
$IDRA "Paper Buy" @ $2.57; PT, $3.09; Stop loss, $$2.27; 5 days.
Elias S
20 Nov 14 07:16:05
$ADAT, $NVLX, $THNS, $IDRA Seeing how they hold; will buy on modest dip.
Stockaholics
20 Nov 14 02:31:02
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $QCOR $FCEL $IDRA
DailyStockPicks
19 Nov 14 21:10:21
$CYNAF $CTH.V rose 17% today on positive Phase 2 data. $2.75 target. http://t.co/5Vy1M3qBcv http://t.co/v3jMrkb9LH $IDRA $BDSI $VIVO $IDXX
Urdu Poetry Shairi
19 Nov 14 20:19:10
MaiN CHaHoN BHi To KaBHi Wo LaFz Na LiKh Pao'N Ga..* + MaHi + JiS mE BaYaN Ho JaYe K KiTni MoHaB'BaT Hai TuJH sE..* $idra
Elias S
19 Nov 14 17:50:13
$IDRA, $ADAT For watchlist tomorrow.
equities.com
19 Nov 14 13:44:19
Leading Health Care Stock for Small-Cap Stars is Receptos Inc. (RCPT) for November 19 $KYTH $IDRA $ATHX $BIOL $RCPT http://t.co/VdPKF0kole
NoanetTrader
19 Nov 14 08:14:51
$IDRA a bit on the thin side, but looks like it could be flagging for a breakout on daily
RC
19 Nov 14 07:24:47
Potential Runners | Momentum Trading with RaginCajun http://t.co/I5hu2CyQla $JASO, $TSL, $SGYP, $YGE , $IDRA, $LL, $PSUN
TBlind
19 Nov 14 07:05:18
$IDRA Idera presents at Stifel Healthcare Conference, NYC today at 4:10.
Stockaholics
19 Nov 14 01:44:07
$CJTF closed up 128.57% Yesterday! New Pick Coming This Week: http://t.co/TOww1JMOlD $QCOR $FCEL $IDRA
ALICETTA
18 Nov 14 23:53:48
$IDRA ...è ora di farle funzionare bene tutte 7!!!ziopera http://t.co/gLaKyuHbPB
Stockaholics
18 Nov 14 20:39:53
$FONU was yesterdays top penny stock! Plus, $MHYS was just announced as our own new pick: http://t.co/W1dUG8Ww2F $QCOR $FCEL $IDRA
Stockaholics
18 Nov 14 14:25:24
$FONU was yesterdays top penny stock! Plus, $MHYS was just announced as our own new pick: http://t.co/W1dUG8Ww2F $QCOR $FCEL $IDRA
Leo Kolivakis
18 Nov 14 12:21:09
Baker Brother biotechs on my radar: $AVNR $BCRX $IDRA $PGNX $SGEN $THLD $XOMA. Also add $TGTX to this list, making a new 52-week high. :)
Penny Stock Secret
18 Nov 14 10:23:00
Yesterday We Made $89,000 In Just One Trade More Info Here http://t.co/SVqoMlijqL .. $VVTV $BIOFR $IDRA
Stockaholics
18 Nov 14 09:13:18
$FONU was yesterdays top penny stock! Plus, $MHYS was just announced as our own new pick: http://t.co/W1dUG8Ww2F $QCOR $FCEL $IDRA
TBlind
18 Nov 14 08:11:15
$IDRA What are folks expecting from company presentation after the bell tomorrow? Potential big deal or no?
Stockaholics
18 Nov 14 01:28:13
$FONU was the top penny stock of the day yesterday! Plus, a new pick coming today: http://t.co/UDHJIasKws $QCOR $FCEL $IDRA
Stockaholics
17 Nov 14 21:20:06
New Penny Stock Pick Coming Tomorrow! Multi-Site Release, Going To Our members first: http://t.co/e8b0jnUMkC $QCOR $FCEL $IDRA
Stockaholics
17 Nov 14 17:30:06
New Penny Stock Pick Coming Tomorrow! Multi-Site Release, Going To Our members first: http://t.co/O7cLXgzwMO $QCOR $FCEL $IDRA
Stockaholics
17 Nov 14 16:34:05
Memberships Rise After 578% Gains On Penny Stock Alerts In One Month! Subscribe Today: http://t.co/2W3yKD2d5Q $QCOR $FCEL $IDRA
Penny Stock Secret
17 Nov 14 11:59:27
Yesterday We Made $89,000 In Just One Trade More Info Here http://t.co/SVqoMlijqL .. $QCOR $FCEL $IDRA
Stockaholics
17 Nov 14 10:52:27
Memberships Rise After 578% Gains On Penny Stock Alerts In One Month! Subscribe Today: http://t.co/2W3yKD2d5Q $QCOR $FCEL $IDRA
Stockaholics
16 Nov 14 23:36:46
Memberships Rise After 578% Gains On Penny Stock Alerts In One Month! Subscribe Today: http://t.co/2W3yKD2d5Q $QCOR $FCEL $IDRA
Stockaholics
16 Nov 14 21:49:06
$BIGG Closed Up 44.44% This Past Friday, As The Breakout Continues! Huge News: http://t.co/qpmUKtkS1n $QCOR $FCEL $IDRA
Stockaholics
16 Nov 14 17:24:56
$BIGG Closed Up 44.44% This Past Friday, As The Breakout Continues! Huge News: http://t.co/BX2gEwT2ed $QCOR $FCEL $IDRA
Stockaholics
16 Nov 14 13:24:25
$BIGG Closed Up 44.44% This Past Friday, As The Breakout Continues! Huge News: http://t.co/BX2gEwT2ed $QCOR $FCEL $IDRA
Stockaholics
16 Nov 14 01:42:30
$BIGG Closed Up 44.44% This Past Friday, As The Breakout Continues! Huge News: http://t.co/BX2gEwT2ed $QCOR $FCEL $IDRA
Stockaholics
16 Nov 14 00:28:26
$BIGG Closed Up 44.44% Yesterday, As The Breakout Continues! Huge News: http://t.co/BX2gEwT2ed $QCOR $FCEL $IDRA
				
				
By  +Follow March 27, 2014 11:11AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.